PARNAX LAB
Back to Balance Sheet
|
PARNAX LAB Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹35 Cr | ₹20 Cr | ₹24 Cr | ₹19 Cr | ₹22 Cr |
What is the latest Total Non-Current Liabilities ratio of PARNAX LAB ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹35 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹24 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹22 Cr |
How is Total Non-Current Liabilities of PARNAX LAB Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹35 Cr | 78.25 | |
Mar2023 | ₹20 Cr | -18.33 | |
Mar2022 | ₹24 Cr | 25.66 | |
Mar2021 | ₹19 Cr | -11.76 | |
Mar2020 | ₹22 Cr | - |
Compare Total Non-Current Liabilities of peers of PARNAX LAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PARNAX LAB | ₹142.8 Cr | -3.1% | 20.5% | 28.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,466.0 Cr | 1.7% | 2% | -0.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,298.0 Cr | 0.4% | -2% | 37.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹127,538.0 Cr | 6% | 10.5% | 13.6% | Stock Analytics | |
CIPLA | ₹127,140.0 Cr | 6.8% | 4.6% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,500.0 Cr | 4.2% | 1.3% | -6.7% | Stock Analytics |
PARNAX LAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PARNAX LAB | -3.1% |
20.5% |
28.8% |
SENSEX | -1% |
-3.2% |
1.6% |
You may also like the below Video Courses